Arformoterol

Arformoterol is the single (R,R)-enantiomer of formoterol, a long-acting beta-2 adrenergic agonist administered by nebulisation for the maintenance treatment of COPD. Simson Pharma's Arformoterol reference standard and impurities support stability-indicating testing for this single-enantiomer respiratory therapy.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Arformoterol Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Arformoterol tartrate
1-(4-(benzyloxy)-3-nitrophenyl)-2-bromoethanone
(R)-N-(2-hydroxy-5-(2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide
Arformoterol tartrate(1S,2R)Isomer
Arformoterol Impurity 11
Arformoterol
Arformoterol Impurity 7
N-(2-Hydroxy-5-((S)-1-hydroxy-2-((S)-1-(4-methoxyphenyl)propan-2-ylamino)ethyl)phenyl)formamide2,3-dihydroxysuccinate
Arformoterol(1R,2S)Isomers
N-(2-hydroxy-5-(1-isopropoxy-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide
N-(2-hydroxy-5-(1-hydroxy-2-((1-(3-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide
Formoterol Impurity 13
N-(2-Hydroxy-5-((R)-1-hydroxy-2-(((R)-1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)-N-nitrosoformamide
N-Nitroso Desformyl Arformoterol
N-Nitroso Desmethyl Arformoterol
N-Nitroso n-Acetyl Arformoterol
N-(2-(benzyloxy)-5-((R)-1-hydroxy-2-(((R)-1-(4-methoxyphenyl)propan-2-yl)benzyl amine)ethyl)phenyl)formamide
(S)-N-(1-phenylpropan-2-yl)formamide
Arformoterol Impurity 12
Formoterol Impurity 21
Formoterol Impurity 15
Formoterol Impurity 28
Formoterol Impurity 32
Arformoterol Impurity 1